Company Quick10K Filing
Patriot Scientific
10-Q 2020-11-30 Filed 2020-12-29
10-Q 2020-08-31 Filed 2020-10-15
10-K 2020-05-31 Filed 2020-08-24
10-Q 2020-02-29 Filed 2020-04-08
10-Q 2019-11-30 Filed 2020-01-14
10-Q 2019-08-31 Filed 2019-10-11
10-K 2019-05-31 Filed 2019-08-29
10-Q 2019-02-28 Filed 2019-04-15
10-Q 2018-11-30 Filed 2019-01-14
10-Q 2018-08-31 Filed 2018-10-15
10-K 2018-05-31 Filed 2018-08-29
10-Q 2018-02-28 Filed 2018-04-16
10-Q 2017-11-30 Filed 2018-01-16
10-Q 2017-08-31 Filed 2017-10-16
10-K 2017-05-31 Filed 2017-08-29
10-Q 2017-02-28 Filed 2017-04-13
10-Q 2016-11-30 Filed 2017-01-17
10-Q 2016-08-31 Filed 2016-10-17
10-K 2016-05-31 Filed 2016-08-29
10-Q 2016-02-29 Filed 2016-04-14
10-Q 2015-11-30 Filed 2016-01-14
10-Q 2015-08-31 Filed 2015-10-15
10-K 2015-05-31 Filed 2015-08-31
10-Q 2015-02-28 Filed 2015-04-14
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-15
10-K 2014-05-31 Filed 2014-08-19
10-Q 2014-02-28 Filed 2014-04-14
10-Q 2013-11-30 Filed 2014-01-14
10-Q 2013-08-31 Filed 2013-10-15
10-Q 2013-02-28 Filed 2013-04-15
10-Q 2012-11-30 Filed 2013-01-14
10-Q 2012-08-31 Filed 2012-10-15
10-K 2012-05-31 Filed 2012-08-29
10-Q 2012-02-29 Filed 2012-04-16
10-Q 2011-11-30 Filed 2012-01-17
10-Q 2011-08-31 Filed 2011-10-17
10-K 2011-05-31 Filed 2011-08-29
10-Q 2011-02-28 Filed 2011-04-11
10-Q 2010-11-30 Filed 2011-01-14
10-Q 2010-08-31 Filed 2010-10-12
10-K 2010-05-31 Filed 2010-08-16
10-Q 2010-02-28 Filed 2010-04-09
10-Q 2009-11-30 Filed 2010-01-11
8-K 2020-08-19
8-K 2019-10-01
8-K 2019-04-12
8-K 2019-04-01
8-K 2018-06-01

Patriot Scientific Financials

PTSC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash5,3365,6886,4664,6996,5367,0017,2207,5737,0596,3545,8624,7164,4493,6173,0122,6794,6004,0843,7241,1602,6943,3021,8169802514451,8072,2982,0591,8951,965986
Accounts Receivable27114
Inventory
PP&E15138875650543473324622113322132111211112
Assets11,25410,1218,9448,1386,9797,4217,3678,4157,8117,8567,3926,8016,1475,7745,5785,1825,0314,9254,3933,8233,4574,3944,0913,7613,4993,1122,9052,5802,3602,1722,1801,925
Accounts Payable111684224026123521953282222455272338381220333613814359104528189
Long-Term Debt
Liabilities3422273271,0487957794527898116922902302916916590707074835259578751101857842234228
Stockholders' Equity10,9129,8948,6177,0916,1847,3446,4228,1377,7137,7407,3006,5115,9175,4835,5085,0164,9414,8554,3233,7503,3744,3414,0323,7043,4123,0612,8042,4952,2822,1301,9461,697
Income Statement ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue
Cost of Revenue3312
Gross Profit10135
R&D170151
SG&A737666623448392238345406439467379469373357248460398342405431322284281328283254274236203144159228
Tax4002508030204320-194130-12000200022002000
Net Income-1,064-1,004-1,246-1,506-8921,546-9121,708-487492-396-651-594-43425-535-75-86-532-573-376967-309-327-293-351-256-309-213-152-184-249
Cash Flow ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating-556-819-313-714-562143-252-340-520-327-349-308-467-332-213-336-551-308-359-360-419-275-231-229-255-186-209-260-107-229
Cash Investing-2,5141,1901,126-1,030302-1,4912,0963,0276-338-99-700200-392-0164202471,384-50-5004501,5497000177-750
Cash Financing-48-19-35-22-14-33-1080-40-44-13700